SOPHIA FOSTER: Open Payments
NPI 1770275711 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,644 in 102 payments from 19 companies in 2025. Trend: 2023 $171 · 2024 $1,691 · 2025 $2,644
Food & beverage: $2,569Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $553 |
| LEO Pharma Inc. | 19 | $550 |
| Regeneron Healthcare Solutions, Inc. | 12 | $365 |
| ABBVIE INC. | 16 | $349 |
| GENZYME CORPORATION | 8 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $115 |
| UCB, Inc. | 5 | $101 |
| Botanix SB Inc | 4 | $97 |
| Lilly USA, LLC | 2 | $47 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $44 |
Products named: TREMFYA, DUPIXENT, ADBRY, ANZUPGO, BOTOX, SKYRIZI, Bimzelx, SOFDRA.
Industry payments across NY — which companies pay providers there.
